The short answer
Cycling does not simply “boost” or “kill” testosterone.
A demanding ride can change testosterone for a short period. That is an acute response, not proof that resting levels will rise or that the workout has become more productive. At the other end of the spectrum, some men with years of high-volume endurance training show persistently lower resting testosterone. Researchers still debate the mechanism, threshold and clinical consequences.
The practical divide is this:
- exercise physiology asks how a session or training history changes a hormone;
- clinical medicine asks whether symptoms plus repeat testing show hypogonadism and why; and
- anti-doping rules ask whether treatment is prohibited and whether a valid exemption applies.
Watts, fatigue and a single blood result cannot answer all three.
Does cycling increase testosterone?
It depends on what “increase” means.
Testosterone can change during and after exercise. The direction and size depend on the session, training status, energy availability, time of day and when the sample is taken. Resistance work and hard intervals can produce an acute response in some studies.
That short-lived change is not the same as a sustained rise in resting testosterone. A systematic review and meta-analysis found that exercise training did not appear to change resting total or free testosterone in insufficiently active, otherwise healthy men. A separate review in older men found inconsistent effects from short-term training.
So train strength to maintain force, muscle and bone. Ride intervals to improve cycling performance. Do not sell either session as testosterone replacement.
Can long-term endurance cycling lower testosterone?
Some chronically endurance-trained men have lower resting total and free testosterone than comparison groups. The pattern has been called the exercise-hypogonadal male condition.
The original endurance-exercise review was careful about its limits: the exact mechanism, the amount of training required and the consequences remained unresolved. A later review of exercising males also describes more than one exercise-related reproductive pattern rather than one universal cyclist diagnosis.
This matters because two bad assumptions sit on either side:
- “Cycling always lowers testosterone.” It does not.
- “Any lower value in an endurance athlete is harmless adaptation.” That is not established either.
Training history belongs in the assessment. It cannot replace it.
Low energy availability is part of the question
High training load and inadequate energy intake often travel together. That makes cause-and-effect harder to separate.
A review of the hypothalamic-pituitary-gonadal axis notes lower testosterone in some male endurance athletes and limited evidence that restricted energy availability affects reproductive hormones. A 2023 mini-review focuses on male endurance runners, low energy availability, performance and testosterone.
The runner evidence does not create an exact calorie or hormone threshold for every cyclist. It does support a better question: is the rider trying to maintain a large endurance load without enough available energy?
Review unplanned weight loss, food restriction, libido, mood, bone stress, recurrent illness, training load and recovery. The REDs and energy-availability guide covers that wider syndrome. Low testosterone can be part of the picture; it does not diagnose REDs by itself.
Symptoms come before an “optimal” target
Fatigue, flat motivation, slow recovery and poor power are real problems. They are also nonspecific.
Sleep loss, depression, anaemia, iron deficiency, thyroid disease, medication effects, infection, low energy availability and training fatigue can look similar. More suggestive testosterone-deficiency features can include reduced libido, fewer spontaneous erections, erectile dysfunction, hot flushes, reduced body hair, loss of muscle or strength, low bone density and infertility.
The Endocrine Society guideline recommends diagnosing hypogonadism only when compatible symptoms and signs occur with unequivocally and consistently low testosterone. The Society's 2026 statement also rejects population-level screening of asymptomatic men.
A coach, app or FTP chart should not convert tiredness into a diagnosis.
How should a male cyclist test testosterone?
Start with a clinical question and a clinician.
For suspected hypogonadism, Endocrine Society guidance recommends accurate total testosterone measurement on two separate fasting mornings. Testosterone varies by day and time and can be affected by food and short-term health conditions.
Free testosterone is useful when indicated—for example, when total testosterone is near the lower limit or a condition alters sex hormone-binding globulin (SHBG). It should be measured or calculated with a validated method. “Free is the only metric” is not what the guideline says.
If repeat results and symptoms support hypogonadism, additional work may include:
- LH and FSH to help distinguish testicular from pituitary or hypothalamic causes;
- SHBG and albumin where free testosterone interpretation is needed;
- prolactin, iron studies or pituitary assessment when the history points there;
- medicines, alcohol, illness, obesity, sleep and energy availability; and
- fertility goals before treatment is considered.
The exact work-up belongs to qualified care. The cyclist blood-testing guide explains why adding every marker to a “performance panel” is not the answer.
Total versus free testosterone
Most circulating testosterone is protein-bound, with a small free fraction. SHBG changes with age and several health conditions, so two men with the same total testosterone can have different free-testosterone estimates.
That does not make total testosterone “junk.” It remains the first-line diagnostic measurement in major clinical guidance. Free testosterone adds information in selected cases and is highly dependent on assay quality and interpretation.
There is also no validated rule that a serious cyclist should sit between the 50th and 75th percentile of the laboratory free-testosterone range. A reference interval is not a cycling performance ladder. Laboratories, methods, units and populations differ.
Treat the result as clinical evidence, not a leaderboard.
What about age and masters cycling?
Population testosterone distributions change with age, but an annual 1–2% decline is not a personal prediction or a diagnosis. Individuals follow different trajectories, and health, body composition, medicines and chronic conditions influence the pattern.
The important distinction is between ageing, potentially reversible functional suppression and organic disease. A low result caused by acute illness, underfuelling or medication is a different problem from primary testicular disease or pituitary damage.
Do not accept “you are over 40” as the whole explanation for significant symptoms. Do not assume age makes testosterone therapy appropriate either.
Does a cycling crash cause low testosterone?
Significant head trauma can damage pituitary function and is a recognised possible cause of secondary hypogonadism. A meaningful head-injury history therefore belongs in a proper assessment.
That is not evidence that every minor cycling crash adds to a hidden hormonal ledger or that a fractured collarbone automatically suppresses testosterone years later. Those claims go beyond what the evidence can establish.
After significant head trauma, persistent neurological, sexual, endocrine or unexplained systemic symptoms deserve medical assessment. Do not diagnose pituitary injury from a podcast story or use supplements to treat it.
The full Dr Mark Gordon conversation remains available on the Roadman Cycling Podcast. Treat it as one expert's framework, not a substitute for clinical guidelines.
Sleep, strength and body composition
Sleep, adequate fuelling, resistance training and a sustainable body composition support health and performance. They may also improve a reversible contributor to a low result in the right person.
They are not guaranteed testosterone treatments.
- Fix chronic sleep restriction because it affects health, recovery and training quality.
- Use strength training to maintain force, muscle and bone, not to chase an acute hormone spike.
- Address obesity with sustainable health care when relevant; avoid crash dieting and low energy availability.
- Review medicines and illness with the prescriber rather than changing them yourself.
- Separate hard sessions because quality and recovery matter, not because a fixed cortisol-to-testosterone ratio prescribes the week.
No supplement stack reliably turns a eugonadal cyclist into a higher-testosterone athlete. Correct a measured nutritional deficiency when qualified care identifies one; do not use zinc, vitamin D, magnesium, DHEA or “test boosters” as hormone therapy by proxy.
TRT is medical treatment, not a recovery product
Testosterone therapy may be appropriate for men with confirmed hypogonadism after the cause, benefits, risks, fertility implications, contraindications and monitoring are discussed.
It is not an evidence-based response to:
- one low or low-normal result;
- ordinary age-related performance change;
- a demanding training block;
- poor recovery without a diagnosis; or
- a desire to restore an old FTP.
The Endocrine Society guideline describes important exclusions and monitoring decisions. A specialist should manage the medical question. Roadman does not prescribe, recommend or optimise TRT.
Can a cyclist race on TRT?
Under the 2026 WADA Prohibited List, testosterone is an S1 anabolic agent prohibited at all times.
A prescription is not automatically a competition exemption. It is also inaccurate to say a TUE is never possible.
WADA's male-hypogonadism TUE physician guidance requires a documented organic cause. Low circulating testosterone without a clear pathological cause, late-onset or age-related decline and low free testosterone alone do not satisfy that guidance.
The practical steps are:
- Check the medication on the current prohibited list or Global DRO.
- Identify the anti-doping authority and rules that apply to your level of competition.
- Ask whether a prospective TUE is required or whether retroactive rules apply.
- Submit the full clinical evidence before the relevant deadline.
- Do not assume a doctor's prescription or an application is approval.
UK Anti-Doping's TUE criteria explain that the treatment must be medically necessary, must not enhance performance beyond a return to normal health, must lack a reasonable permitted alternative and must not result from prior prohibited use. Other countries and international-level cycling can have a different responsible authority.
Health comes first in urgent care. Competition permission is a separate administrative and anti-doping decision.
What the Roadman app can—and cannot—do
The app can help a rider store:
- symptoms and why testing was ordered;
- sample date, time, fasting state, units and laboratory interval;
- total testosterone, SHBG and any clinically indicated free result;
- illness, sleep, energy availability and recent training;
- the clinician's follow-up plan; and
- whether anti-doping advice is required.
It cannot diagnose hypogonadism, calculate an athlete-optimal target, recommend testosterone, determine a TUE or clear someone to race.
Roadman is building the useful middle layer: cleaner longitudinal context for training and clinical conversations without pretending training data is a medical licence. Join the single app waiting list for launch access.
The Roadman decision
Do not chase a testosterone spike from a workout.
Do not let one “within range” or low-normal result end a legitimate clinical investigation when symptoms and signs persist.
Repeat the right measurement, assess the cause, correct reversible problems, use medical treatment only for a medical diagnosis and treat anti-doping compliance as a separate non-negotiable job.